4 Patents
- 0 cites
- US122342932025Treatment for Primary Amyloidosis with Anti-bcma Binding Protein
Glaxosmithkline Intellectual Property Development Limited
0 cites - US122275852025Anti-bcma Antibody Drug Conjugate Combination Treatment for Cancer
Glaxosmithkline Intellectual Property Development Limited
0 cites - 0 cites